Group 1 - The company, 康臣药业 (01681), announced a share buyback plan on November 4, 2025, involving an expenditure of HKD 7.3134 million to repurchase 495,000 shares [1] - The buyback price range is set between HKD 14.46 and HKD 14.91 per share [1]

Core Viewpoint - 康臣药业 announced a share buyback plan, indicating confidence in its stock value and potential for future growth [1] Group 1: Buyback Details - The company repurchased 495,000 shares at a total cost of HKD 7.3134 million [1] - The buyback price ranged from HKD 14.46 to HKD 14.91 per share [1]

Core Viewpoint - 康臣药业 announced a share buyback plan, indicating confidence in its stock value and potential for future growth [1] Summary by Category Company Actions - 康臣药业 plans to repurchase 495,000 shares at a total cost of HKD 7.3134 million [1] - The buyback price ranges from HKD 14.46 to HKD 14.91 per share [1]

表格類別： 股票 狀態： 新提交 公司名稱： 康臣葯業集團有限公司 呈交日期： 2025年11月4日 如上市發行人的已發行股份或庫存股份出現變動而須根據《香港聯合交易所有限公司（「香港聯交所」）證券上市規則》(「《主板上市規則》」)第13.25A條 / 《香港聯合交易所有限公司GEM證券 上市規則》(「《GEM上市規則》」)第17.27A條作出披露，必須填妥第一章節 。 | 第一章節 | | | | | | | | | --- | --- | --- | --- | --- | --- | --- | --- | | 1. 股份分類 | 普通股 | 股份類別 | 不適用 | | 於香港聯交所上市 | 是 | | | 證券代號 (如上市) | 01681 | 說明 | | | | | | | A. 已發行股份或庫存股份變動 | | | | | | | | | | | 已發行股份（不包括庫存股份）變動 | | | 庫存股份變動 | | | | | 事件 | 已發行股份（不包括庫存股份）數 目 | | 佔有關事件前的現有已發 行股份（不包括庫存股 份）數目百分比 (註3) | 庫存股份數目 | 每股發行/出售價 ( ...

Summary of Key Points Core Viewpoint - 康臣药业 has been actively repurchasing its shares, indicating a strategy to support its stock price amidst recent declines [2]. Repurchase Activity - On November 3, 康臣药业 repurchased 201,000 shares at a price range of HKD 15.030 to HKD 15.080, totaling HKD 3.0298 million [2]. - The stock closed at HKD 15.080 on the same day, reflecting a slight increase of 0.33% with a total trading volume of HKD 38.4015 million [2]. - Since October 14, the company has conducted share repurchases for 14 consecutive days, acquiring a total of 3.201 million shares for a cumulative amount of HKD 48.7059 million [2]. - During this period, the stock has experienced a cumulative decline of 5.75% [2]. Year-to-Date Repurchase Summary - Year-to-date, 康臣药业 has executed 32 repurchase transactions, acquiring a total of 8.396 million shares for a total expenditure of HKD 107 million [2]. Detailed Repurchase Data - A detailed table of repurchase activities shows the number of shares repurchased, highest and lowest prices, and total amounts for each transaction from July to November 2025 [3].

智通财经APP讯，康臣药业(01681)发布公告，于2025年11月3日，该公司斥资302.98万港元回购20.1万 股。 ...

康臣药业(01681)发布公告，于2025年11月3日，该公司斥资302.98万港元回购20.1万股。 ...

Group 1 - Company announced a share buyback of 200,000 shares at a cost of 3.03 million HKD [1] - The buyback price per share ranged from 15.03 to 15.08 HKD [1]

FF305 公司名稱： 康臣葯業集團有限公司 呈交日期： 2025年11月3日 如上市發行人的已發行股份或庫存股份出現變動而須根據《香港聯合交易所有限公司（「香港聯交所」）證券上市規則》(「《主板上市規則》」)第13.25A條 / 《香港聯合交易所有限公司GEM證券 上市規則》(「《GEM上市規則》」)第17.27A條作出披露，必須填妥第一章節 。 | 第一章節 | | | | | | | | --- | --- | --- | --- | --- | --- | --- | | 1. 股份分類 | 普通股 | 股份類別 | 不適用 | 於香港聯交所上市 | 是 | | | 證券代號 (如上市) | 01681 | 說明 | | | | | | A. 已發行股份或庫存股份變動 | | | | | | | | | | | 已發行股份（不包括庫存股份）變動 | 庫存股份變動 | | | | | 事件 | 已發行股份（不包括庫存股份）數 目 | 佔有關事件前的現有已發 行股份（不包括庫存股 份）數目百分比 (註3) | 庫存股份數目 | 每股發行/出售價 (註4) | 已發行股份總數 | | 於下列日期開始時的結存 ...

股份發行人及根據《上市規則》第十九B章上市的香港預託證券發行人的證券變動月報表 致：香港交易及結算所有限公司 公司名稱: 康臣葯業集團有限公司 呈交日期: 2025年11月3日 I. 法定/註冊股本變動 | 1. 股份分類 | 普通股 | 股份類別 | 不適用 | | | 於香港聯交所上市 (註1) | | 是 | | | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | | 證券代號 (如上市) | 01681 | 說明 | | | | | | | | | | | 法定/註冊股份數目 | | | 面值 | | | 法定/註冊股本 | | | 上月底結存 | | | 5,000,000,000 | HKD | | 0.1 | HKD | | 500,000,000 | | 增加 / 減少 (-) | | | | | | | HKD | | | | 本月底結存 | | | 5,000,000,000 | HKD | | 0.1 | HKD | | 500,000,000 | 本月底法定/註冊股本總額： HKD 500,000,000 FF30 ...